Stockhead TV
At Argent BioPharma, our mission is to revolutionize healthcare through pioneering innovation.
We go beyond traditional disease management by exploring the intricacies of the immune system and harnessing cutting-edge technologies in our research and development endeavors.
Through our commitment to advancing medical science, we aim to reshape the landscape of global healthcare by addressing unmet needs and offering hope to underserved populations worldwide.
Our vision encompasses becoming a leading biopharmaceutical company renowned for groundbreaking medical treatments. By embracing NanoPolyPharmacology, we strive to introduce impactful solutions that elevate standards within the life sciences industry. Our dedication extends to ensuring accessibility to innovative therapies for communities overlooked by conventional medical approaches, thereby bridging healthcare disparities on a global scale.
As we progress on this ambitious path, we invite you to follow our journey and be a part of a transformative shift in healthcare. At Argent BioPharma, we’re not just changing treatments; we’re changing lives.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
MGC Pharma set to commence Phase III clinical trial on CimetrA to treat COVID-19 patients
Health & Biotech
Weed Week: Amazon all-in on marijuana; free joints for jabs and Creso Pharma dual-listed in US
Health & Biotech
Why these 4 ASX cannabis stocks got investors’ attention today
Health & Biotech
MGC Pharma makes breakthrough in Ireland for cannabis-based epilepsy drug, CannEpil
News
ScoPo’s Powerplays: Mental health takes centre stage; Actinogen to progress Alzheimer’s study
Health & Biotech
MGC Pharma to commence three vital clinical trials in 2021
Health & Biotech
These ASX biotechs are on the verge of releasing Phase III clinical trial results
Health & Biotech
MGC Pharma ready to march ahead with three clinical trials in 2021
Health & Biotech
MGC Pharma submits patent for COVID-19 inflammation drug CimetrA, ahead of Phase III trials
Health & Biotech
Confusion and selloff as Credit Suisse pulls plug on US cannabis stocks
Health & Biotech
MGC Pharma announces exciting new developments in the fight against COVID-19
Health & Biotech
MGC Pharma builds on momentum with a new $1 million order
Health & Biotech
MGC’s COVID-19 treatment spray takes big step forward in North America
Health & Biotech
MGC Pharma acquires clinical trials research company MediCaNL
News
ASX Small Cap Lunch Wrap: Today’s high flyers and sinking ships
Health & Biotech
MGC Pharma delivers first batch order to Swiss PharmaCan, notches record sales quarter
Health & Biotech